Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will latisse patent expire?Novartis patent term dabrafenib?When oxcarbazepine patent expired?When will generic fiasap insulin be available?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for simponi
Yes. Simponi (golimumab) is used to treat rheumatoid arthritis in certain people. It’s prescribed as a treatment option for rheumatoid arthritis and is taken with other therapies as directed by a clinician.
Simponi is approved for rheumatoid arthritis, including use in combination with other rheumatoid arthritis medicines, depending on the patient’s situation and prior treatment history.
In practice, Simponi is given as an injection. The exact dosing schedule and whether it’s used alone or with other disease-modifying drugs depend on the prescribing plan for the individual patient.
Other Questions About Simponi :